Dias and colleagues found that reducing metallothionein 2A levels using siRNA lowered MMP-9 and EGF protein levels, leading to decreased proliferation, migration, and invasion in human oral squamous cell carcinoma cells [23]. Here, MT2A is linked to oral cavity squamous cell carcinoma.